Authors’ addresses: Krishna Pandey, Prabhat K. Sinha, Vidyan N. Ravidas, Nawin Kumar, Neena Verma, Chandra S. Lal, Sanjeev Bimal, and Sujit K. Bhattacharya, Rajendra Memorial Research Institute of Medical Sciences, Agam Kuan, PO Gulzarbagh, Patna 800007, Bihar, India. Dipika Sur, National Institute of Cholera and Enteric Diseases, P-33, CIT Road, Scheme XM, Beliaghata, Kolkata 700010, India.
World Bank, 2003. HIV/AIDS in South Asia, A Threat to Development, 2003. South Asia HIV/AIDS Update, World Bank Report. Washington, DC: World Bank.
Thakur CP, Sinha PK, Singh RK, Hassan SM, Narain S, 2000. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence in India. Trans R Soc Trop Med Hyg. 94 :696–697.
Sinha PK, Rabidas VN, Pandey K, Verma N, Gupta AK, Ranjan A, Das P, Bhattacharya SK, 2003. Visceral leishmaniasis and HIV coinfection in Bihar, India (letter). J Acquir Immune Defic Syndr 32 :115–116.
Thakur CP, Narayan S, Ranjan A, 2003. Kala-azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing? (letter). J Acquir Immune Defic Syndr 32 :572–573.
Russo R, Nigro L, Panarello G, Montineri A, 2003. Clinical survey of leishmaniasis/HIV co-infection in Catania, Italy: the impact of highly active antiretroviral therapy (HAART). Ann Trop Med Parasitol 97 :149–155.
Sinha PK, Ranjan A, Siddique NA, Anil CK, Priya A, Das P, Bhattacharya SK, 2003. Usefulness of voluntary counseling and testing center for HIV/AIDS: Bihar as an example. J Acquir Immune Defic Syndr 33 :407–408.
Bhattacharya SK, Jha TK, Sundar S, Thakur CP, Engel J, Sindermann H, Junge K, Karbwang J, Bryceson AD, Berman JD, 2004. Efficacy and tolerability of miltefosine for chsildhood visceral leishmaniasis in India. Clin Infect Dis 38 :217–221.